- Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
-
Nishikawa N, Hatano T, Kamiyama D, Haginiwa-Hasegawa H, Oyama G, Hattori N
- KMID: 2533698
- J Mov Disord.
- 2022 Sep;15(3):290-292.
- doi: 10.14802/jmd.22021
-
- CITED
-
- Close
- SHARE
-
- Close
- Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey
-
Ogawa M, Oyama G, Sekimoto S, Hatano T, Hattori N
- KMID: 2525090
- J Mov Disord.
- 2022 Jan;15(1):58-61.
- doi: 10.14802/jmd.21096
Objective Using telemedicine is a way to improve the accessibility of specialists for patients with Parkinson’s disease (PD); however, it is not widely used in Japan. We investigated the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Rescue Levodopa/Carbidopa Intestinal Gel for Secondary Deep Brain Stimulation Failure
-
Bautista J, Oyama G, Nuermaimaiti M, Sekimoto S, Sasaki F, Hatano T, Nishioka K, Ito M, Umemura A, Ishibashi , Shimo Y, Hattori N
- KMID: 2501670
- J Mov Disord.
- 2020 Jan;13(1):57-61.
- doi: 10.14802/jmd.19051
Objective The long-term efficacy of deep brain stimulation (DBS) for motor fluctuations in advanced Parkinson’s disease (PD) has been well established; however, motor fluctuations may recur over time despite multiple... -
- CITED
-
- Close
- SHARE
-
- Close
- α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders
-
Hatano T, Okuzumi A, Matsumoto G, Tsunemi T, Hattori N
- KMID: 2554687
- J Mov Disord.
- 2024 Apr;17(2):127-137.
- doi: 10.14802/jmd.24075
Mutations in the SNCA gene, which encodes α-synuclein (α-syn), play a key role in the development of genetic Parkinson’s disease (PD). α-Syn is a major component of Lewy bodies in... -
- CITED
-
- Close
- SHARE
-
- Close
